Alerts will be sent to your verified email
Verify EmailSHELTER
|
Shelter Pharma
|
Onyx Biotec
|
Phaarmasia
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.24 % | 13.47 % | -9.08 % |
|
5yr average Equity Multiplier
|
1.33 | 2.51 | 2.3 |
|
5yr Average Asset Turnover Ratio
|
1.65 | 0.82 | 0.96 |
|
5yr Avg Net Profit Margin
|
10.09 % | 6.72 % | -4.04 % |
|
Price to Book
|
1.45 | 1.13 | 5.59 |
|
P/E
|
8.53 | 12.7 | 77.09 |
|
5yr Avg Cash Conversion Cycle
|
138.55 Days | 36.81 Days | -236.72 Days |
|
Inventory Days
|
71.81 Days | 48.71 Days | 79.69 Days |
|
Days Receivable
|
66.01 Days | 104.89 Days | 83.55 Days |
|
Days Payable
|
6.41 Days | 101.26 Days | 340.86 Days |
|
5yr Average Interest Coverage Ratio
|
84.13 | 4.89 | -92.68 |
|
5yr Avg ROCE
|
25.47 % | 12.63 % | -8.87 % |
|
5yr Avg Operating Profit Margin
|
14.81 % | 14.14 % | -5.39 % |
|
5 yr average Debt to Equity
|
0.03 | 0.95 | 0.0 |
|
5yr CAGR Net Profit
|
182.84 % | 8.12 % | n/a |
|
5yr Average Return on Assets
|
13.79 % | 5.64 % | -3.86 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.32 % | 65.1 % | 73.51 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.57 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shelter Pharma
|
Onyx Biotec
|
Phaarmasia
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|